Offering expertise on the program are OB-GYN Dr. Donna G. Ivery, Neumours infection expert Chad Neilsen, and Dr. Dacre Knight ...

Purpose: Pharmacotherapeutic options for the treatment of preeclampsia are reviewed. Summary: Risk factors for the development of preeclampsia include microvascular diseases, such as diabetes ...

The introduction of new agents immunomodulatory drugs (IMiDs) and proteasome inhibitors has brought a major shift in therapeutic paradigm in the treatment of newly diagnosed and refractory ...

Accreditation: Oregon Health & Science University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.